Last week, Portugal’s Parliament voted upon the right for its citizens to receive and gain prescriptions to cannabis-based medicines from their doctor. The move is expected to help reduce patients dependence on pharmaceutical grade synthetic opioids in Portugal.
More and more countries involved in the European Union have decided to join the seemingly worldwide movement to legalize cannabis as a medicine. Country’s like Denmark, Germany, Greece, Italy, the Netherlands, Switzerland, and Turkey have already legalized the medicinal use of cannabis.
The final bill did not include the right for Portuguese citizens to grow cannabis within their residence, a topic that was debated in parliament for months. The new bill now lays in the hands of Portugal’s President Marcelo Rebelo de Souza. If approved by the President, doctors throughout the country will be capable of prescribing medicinal cannabis and patients will be able to fill their perceptions only at pharmacies on July 1, 2018.
You may be interested
Lender420 Provides Funding Solutions to Fit Your Company’s Equipment NeedsEditor - September 24, 2018
Purchasing equipment involved in the cultivation, processing, manufacturing, and distribution of the cannabinoid-derived products can be one of the most expensive costs of setting up a successful…
Elixinol Global to increase ownership in Elixinol Japan to 50.5%Editor - September 24, 2018
Public company Elixinol Global Limited (ASX: EXL; OTCQX: ELLXF), a prominent producer of industrial hemp derived CBD products announced yesterday that its wholly-owned subsidiary, EXL International Holdings,…
Canopy River Begins Trading on the Toronto Stock Exchange (TSX)Editor - September 21, 2018
Yesterday, Canopy Rivers Inc. (TSXV:RIV) announced that their company has began trading on the TSX Venture Exchange under the ticker symbol RIV. The company works in conjunction with…